Clinical Trial Update: A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial is evaluating LBL-024 as monotherapy and in combination with LBL-007 or Toripalimab in patients with advanced melanoma. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• LBL-007
• LBL-024
• Toripalimab (Toripalimab)

Snippet

Sponsor: Nanjing Leads Biolabs Co.,Ltd | Conditions: Advanced Melanoma | Phase 1, Phase 2 | Status: RECRUITING